Tomer Kariv, Director at LogicBio Therapeutics, Inc. (LOGC), bought 784,643 shares at $10.00 ($4.2M) on 2018-10-23, disclosed to the SEC on 2018-10-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 364,643 | $0 | 0.0% |
| 2 | $10.00 | 100,849 | $1.0M | 24.0% |
| 3 | $10.00 | 112,000 | $1.1M | 26.7% |
| 4 | $10.00 | 207,151 | $2.1M | 49.3% |
| Total | $5.35 avg | 784,643 | $4.2M | 100% |
| Filing → |
| ELOX | BUY | 2019-06-26 | $1.8M | — | Filing → |
| VBIV | BUY | 2018-12-18 | $4.0M | — | Filing → |
| ELOX | BUY | 2018-05-01 | $6.8M | — | Filing → |